Doug Hampton 
DUBLIN, June 2, 2023 /PRNewswire/ — The “Autoinjectors Global Market Report 2023” report has been added to ResearchAndMarkets.com’s offering. This report provides strategists, marketers and senior management with the critical information they need to assess the market. The global autoinjectors market grew from $2.47 billion in 2022 to $3.01 billion in 2023 at a compound annual … Read more
SAN DIEGO et SAN JOSÉ, Californie, 3 juin 2023 /PRNewswire/ — Invivoscribe et Complete Genomics ont annoncé aujourd’hui avoir conclu un partenariat pour développer et commercialiser des tests de biomarqueurs sur les plateformes NGS de Complete Genomics. Le territoire est mondial et les domaines sont l’oncologie et la recherche sur le cancer. Selon les termes de l’accord, Invivoscribe … Read more
DUBLIN, June 2, 2023 /PRNewswire/ — The “Hemoglobin A1c Testing Devices Global Market Report 2023” report has been added to ResearchAndMarkets.com’s offering. This report provides strategists, marketers and senior management with the critical information they need to assess the market. The global hemoglobin A1c testing devices market is expected to grow from $1.54 billion in 2022 … Read more
ROCKVILLE, Md. and SUZHOU, China, June 2, 2023 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and other major diseases, announced that the Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) has granted … Read more
DUBLIN, June 2, 2023 /PRNewswire/ — The “Global Musculoskeletal Partnering 2016-2023: Deal Trends, Players and Financials” report has been added to ResearchAndMarkets.com’s offering. This report provides the full collection of musculoskeletal disease deals signed between the world’s pharmaceutical and biotechnology companies since 2016. Trends in musculoskeletal partnering deals Financial deal terms for headline, upfront and royalty … Read more
Results presented today at ASCO 2023 and concurrently published in The Lancet Oncology demonstrate meaningful clinical benefit including antitumor activity, confirmed objective response rate (cORR) of 41.3%, median duration of response (DOR) of 12.9 months, and median progression-free survival (PFS) of 5.5 months (median study follow-up time of 12.4 months) Biliary tract cancers (BTC) are an … Read more
VANCOUVER, BC, June 2, 2023 /PRNewswire/ – Asep Medical Holdings Inc. (“Asep Inc.” or the “Company”) (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) announces the ground-breaking use of artificial intelligence (AI) to rapidly identify infections at increased risk of severe sepsis. The method was developed by the Hancock Lab, under the guidance of Dr. Robert E.W. … Read more
Nominierung von LMNL6326 als führender präklinischer Kandidat für das OXER1-Antagonisten-Entwicklungsprogramm zur Behandlung eosinophil bedingter Erkrankungen Fortschritte bei der Beantragung einer klinischen Studie (CTA), die präklinische Studien mit LMNL6511 ermöglicht, um den CTA-Antrag für eine klinische Phase-1-Studie in H2 2023 zu unterstützen Gewinnung vonErkenntnissen aus präklinischen in-vivo -Studien mit LMNL6511 zur weiteren Verfeinerung des Spektrums möglicher … Read more
CHICAGO, June 2, 2023 /PRNewswire/ — ASCO 2023 – McCormick Place, In advance of a new Current Procedural Terminology (CPT) Category III code that will go into effect on July 1st, Perthera, the leader in AI precision oncology solutions, introduced its latest generation of clinical support tools, including Perthera Lab Direct and Perthera RWE Navigator. … Read more
— Patricia Mae Garcia Santos, MD, MS, receives annual Conquer Cancer-Women Leaders in Oncology “Women Who Conquer Cancer” Young Investigator Award — — Tafadzwa L. Chaunzwa, MD, MHS, receives annual Conquer Cancer-Vaniam Group LLC Young Investigator Award, dedicated to Black, African, or African American cancer researchers — CHICAGO, June 2, 2023 /PRNewswire/ — Conquer Cancer®, … Read more